Loading...
Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?
Canuti, Marta ; Bianchi, Silvia ; Kolb, Otto ; ; ; Gori, Maria ; Fappani, Clara ; Colzani, Daniela ; Borghi, Elisa ; Zuccotti, Gianvincenzo ... show 3 more
Canuti, Marta
Bianchi, Silvia
Kolb, Otto
Gori, Maria
Fappani, Clara
Colzani, Daniela
Borghi, Elisa
Zuccotti, Gianvincenzo
Citations
Altmetric:
Genre
Journal article
Date
2022-03-16
Advisor
Committee member
Department
Biology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1136/bmjgh-2021-008386
Abstract
Two years after the start of the COVID-19 pandemic, key questions about the emergence of its aetiological agent (SARS-CoV-2) remain a matter of considerable debate. Identifying when SARS-CoV-2 began spreading among people is one of those questions. Although the current canonically accepted timeline hypothesises viral emergence in Wuhan, China, in November or December 2019, a growing body of diverse studies provides evidence that the virus may have been spreading worldwide weeks, or even months, prior to that time. However, the hypothesis of earlier SARS-CoV-2 circulation is often dismissed with prejudicial scepticism and experimental studies pointing to early origins are frequently and speculatively attributed to false-positive tests. In this paper, we critically review current evidence that SARS-CoV-2 had been circulating prior to December of 2019, and emphasise how, despite some scientific limitations, this hypothesis should no longer be ignored and considered sufficient to warrant further larger-scale studies to determine its veracity.
Description
Citation
Canuti M, Bianchi S, Kolbl O, et alWaiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?BMJ Global Health 2022;7:e008386.
Citation to related work
BMJ Publications
Has part
BMJ Global Health, Vol. 7, No. 3
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu